Cocoon Bioscience — Series A (estimated) · €15M

Cocoon Bioscience, an Algenex spin-out that uses cocooned insects as natural bioreactors to make specialty enzymes and growth factors for mRNA synthesis, sequencing and cultivated meat, closed a €15 million round (~$16M). The company's release names Columbus Venture Partners and Cleon Capital as co-leads while Spanish trade press credits Viscofan and Cleon; Viscofan, North South Ventures and former Algenex shareholders also invested, funding scale-up of its Basque Country (Derio/Zamudio) plant.

LeadColumbus Venture Partners RoundSeries A (estimated) Announced14 Mar 2023 CityBilbao · reported Madrid SectorHealthtech & Bio · Biotech / industrial biotechnology Source W

Something wrong? Suggest a correction →